Abstract PO1-01-01: ECOG-ACRIN EA1211: Interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT Trial)
Year: 2024
Type: conference-abstract
Source: Cancer Research
Authors: Heather Jacene, Constantine Gatsonis, Roisin Connolly, Brian Burnette, Erica Stringer-Reasor, Maeve Hennessy, Justin Romanoff, Alexander Taurone, Ciara O'Sullivan, H. T. Carisa Le-Petross, Courtney Lawhn Heath, Vered Stearns, Amy Fowler, Shou-Ching Tang, Karla A Sepulveda, Angela DeMichele, David Mankoff, Antonio Wolff
Institutions: Dana-Farber Brigham Cancer Center, Brown University, University College Cork, St. Vincent Hospital, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Mayo Clinic, The University of Texas MD Anderson Cancer Center, University of California System, Johns Hopkins University, University of Wisconsin–Madison, Louisiana State University Health Sciences Center New Orleans, Baylor College of Medicine, University of Pennsylvania, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4396591092